Response of prothrombin time to rivaroxaban in Japanese patients with non-valvular atrial fibrillation: Characteristics of 5 representative reagents in Japan (CVI ARO 1)

Shinya Suzuki, Takeshi Yamashita, Hidefumi Kasai, Takayuki Otsuka, Koichi Sagara

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)73-75
Number of pages3
JournalThrombosis Research
Volume150
DOIs
Publication statusPublished - 2017 Feb 1
Externally publishedYes

Fingerprint

Prothrombin Time
Atrial Fibrillation
Japan
Stroke
Rivaroxaban
Factor Xa Inhibitors
Dabigatran

Keywords

  • Anticoagulation
  • Atrial fibrillation
  • Dabigatran

ASJC Scopus subject areas

  • Hematology

Cite this

Response of prothrombin time to rivaroxaban in Japanese patients with non-valvular atrial fibrillation : Characteristics of 5 representative reagents in Japan (CVI ARO 1). / Suzuki, Shinya; Yamashita, Takeshi; Kasai, Hidefumi; Otsuka, Takayuki; Sagara, Koichi.

In: Thrombosis Research, Vol. 150, 01.02.2017, p. 73-75.

Research output: Contribution to journalLetter

@article{d88e28262f7c4a7a98b5799940cc2fcc,
title = "Response of prothrombin time to rivaroxaban in Japanese patients with non-valvular atrial fibrillation: Characteristics of 5 representative reagents in Japan (CVI ARO 1)",
keywords = "Anticoagulation, Atrial fibrillation, Dabigatran",
author = "Shinya Suzuki and Takeshi Yamashita and Hidefumi Kasai and Takayuki Otsuka and Koichi Sagara",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.thromres.2016.12.025",
language = "English",
volume = "150",
pages = "73--75",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Response of prothrombin time to rivaroxaban in Japanese patients with non-valvular atrial fibrillation

T2 - Characteristics of 5 representative reagents in Japan (CVI ARO 1)

AU - Suzuki, Shinya

AU - Yamashita, Takeshi

AU - Kasai, Hidefumi

AU - Otsuka, Takayuki

AU - Sagara, Koichi

PY - 2017/2/1

Y1 - 2017/2/1

KW - Anticoagulation

KW - Atrial fibrillation

KW - Dabigatran

UR - http://www.scopus.com/inward/record.url?scp=85007414058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007414058&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2016.12.025

DO - 10.1016/j.thromres.2016.12.025

M3 - Letter

C2 - 28043042

AN - SCOPUS:85007414058

VL - 150

SP - 73

EP - 75

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

ER -